NASDAQ:QTI • US7469623075
The current stock price of QTI is 6.02 USD. Today QTI is up by 0.33%. In the past month the price increased by 20.97%.
ChartMill assigns a technical rating of 4 / 10 to QTI.
ChartMill assigns a fundamental rating of 2 / 10 to QTI. Both the profitability and financial health of QTI have multiple concerns.
On February 18, 2026 QTI reported an EPS of -0.1 and a revenue of 8.28M. The company beat EPS expectations (13.9% surprise) and beat revenue expectations (5.71% surprise).
6 analysts have analysed QTI and the average price target is 11.83 USD. This implies a price increase of 96.54% is expected in the next year compared to the current price of 6.02.
For the next year, analysts expect an EPS growth of 94.98% and a revenue growth 111.17% for QTI
Over the last trailing twelve months QTI reported a non-GAAP Earnings per Share(EPS) of -2.21. The EPS decreased by -12.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -91.58% | ||
| ROE | -327.1% | ||
| Debt/Equity | 0.71 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.61 | 190.38B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.29 | 174.071B | ||
| SYK | STRYKER CORP | 24.19 | 139.513B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.11 | 105.876B | ||
| IDXX | IDEXX LABORATORIES INC | 41.18 | 48.442B | ||
| BDX | BECTON DICKINSON AND CO | 12.14 | 47.586B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.34 | 47.376B | ||
| RMD | RESMED INC | 20.6 | 36.838B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.63 | 33.849B | ||
| DXCM | DEXCOM INC | 27.04 | 26.209B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11 | 18.413B | ||
| HOLX | HOLOGIC INC | 15.4 | 16.908B | ||
| PODD | INSULET CORP | 37.18 | 16.686B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
QT Imaging Holdings, Inc. is a medical device company, which engages in the research, development, and commercialization of body imaging systems using low energy sound. The company is headquartered in Novato, California. The company went IPO on 2021-09-24. The firm's products include QTI Breast Acoustic CT Scanner and QTviewer Software. QTI’s Breast Acoustic CT scanner with QTViewer viewer software is the only three-dimensional (3D) imaging device to receive United States Food and Drug Administration (FDA) clearance for use as a transmission and reflection ultrasonic imaging system of a patients breast. QTviewer is its proprietary image viewing and analysis platform, purpose-built to interpret the rich, quantitative datasets generated by the QTI Breast Acoustic CT™ scanner. The QTviewer allows users to rotate, zoom, and cross-navigate entire breast volumes. Whether isolating lesions or exploring architectural distortion, radiologists can interact with the data dynamically to gain an understanding of tissue structure and lesion morphology.
QT IMAGING HOLDINGS INC
3 Hamilton Landing, Suite 160
Novato CALIFORNIA US
Employees: 20
Phone: 13026587581
QT Imaging Holdings, Inc. is a medical device company, which engages in the research, development, and commercialization of body imaging systems using low energy sound. The company is headquartered in Novato, California. The company went IPO on 2021-09-24. The firm's products include QTI Breast Acoustic CT Scanner and QTviewer Software. QTI’s Breast Acoustic CT scanner with QTViewer viewer software is the only three-dimensional (3D) imaging device to receive United States Food and Drug Administration (FDA) clearance for use as a transmission and reflection ultrasonic imaging system of a patients breast. QTviewer is its proprietary image viewing and analysis platform, purpose-built to interpret the rich, quantitative datasets generated by the QTI Breast Acoustic CT™ scanner. The QTviewer allows users to rotate, zoom, and cross-navigate entire breast volumes. Whether isolating lesions or exploring architectural distortion, radiologists can interact with the data dynamically to gain an understanding of tissue structure and lesion morphology.
The current stock price of QTI is 6.02 USD. The price increased by 0.33% in the last trading session.
QTI does not pay a dividend.
QTI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
QT IMAGING HOLDINGS INC (QTI) will report earnings on 2026-05-11.
You can find the ownership structure of QT IMAGING HOLDINGS INC (QTI) on the Ownership tab.
The outstanding short interest for QT IMAGING HOLDINGS INC (QTI) is 2.01% of its float.